Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Other forms exist on the market, including NR hydrogen malate, but these boast too little research in humans to verify their safety and efficacy
All methods were carried out in accordance with relevant guidelines and regulation
is research-use grey-market material
Retatrutide (LY3437943) is an investigational triple hormone receptor agonist that activates: GLP-1 (glucagon-like peptide-1) receptor GIP (glucose-dependent insulinotropic polypeptide) receptor Glucagon (GCG) receptor This triple G mechanism targets multiple pathways for appetite control, insulin sensitivity, glucose regulation, and energy/fat metabolismpotentially offering greater effects than dual (GLP-1/GIP) or single agonists
Although the availability of doses has increased since demand for weight loss medications is still at a high in the United States
US$ 25.15
US$ 25.06
US$ 24.18
US$ 23.15
US$ 23.59
